The independent source for health policy research, polling, and news.
881-900 of 1,606 results
Advocates for a single payer health care system say it would be more efficient, but other analysts predict that such an unprecedented change could be extremely disruptive to a key part of the nation’s economy.
The president made the proposal as part of a comprehensive look at the Affordable Care Act’s legacy in an article under his byline in the Journal of the American Medical Association.
The decision runs counter to a Senate committee that voted to strip the $52 million appropriation for the State Health Insurance Assistance Program, which helps beneficiaries understand their Medicare coverage and helps them with billing issues.
A new health benefit available to millions of Californians encourages people to discuss end-of-life care options with their doctors.
A Health Affairs study determines that Part D spending went down slightly on prescription drugs for which medical marijuana is viewed as a possible alternative.
A study in Health Affairs finds Medicare Part D beneficiaries were charged copays averaging 10.5 times more for Crestor and Nexium than generic drugs would have cost them.
The changes announced Tuesday seek to eliminate the backlog by 2021.
The U.S Preventive Services Task Force recently expanded the list of approved colorectal cancer screening tests. Here’s a primer on these various tests and how they might be covered now and in the future by health insurance.
It’s not clear yet if the full Senate or House will concur in the plan to cut funding for the State Health Insurance Assistance Program, which operates in all states and gives beneficiaries free advice on enrollment in drug and insurance plans, appealing coverage decisions and applying for financial subsidies.
The Medicare Payment Advisory Commission outlined a package of changes to Medicare’s drug program that could save billions of dollars.
Although there is widespread agreement on the need to let people know if they haven’t been admitted, the language proposed by federal officials hasn’t satisfied everyone.
Investigators from the GAO call for HHS to improve oversight of the Medicare appeals process and streamline it to make sure repetitive claims are handled more efficiently.
The plans, which do not qualify as coverage under the Affordable Care Act and put consumers at risk of a tax penalty, can siphon healthy people away from the online marketplaces because they are generally less expensive.
Researchers report that performance standards set by federal health officials may have led to many patients being dropped from transplant lists without improving survival rates.
Thousands of Floridians patronize storefront businesses that help them buy cheaper drugs online from Canada and other countries, but the Food and Drug Administration calls the practice illegal and risky.
The Missouri Hospital Association objects to the formula for setting the federal penalties because it does not factor in the number of patients who are poor or in bad health. It is seeking to generate consumer interest in the penalties.
A proposal to change the way Medicare pays for some drugs has set off intense reaction and lobbying — all tied to a common theme: How far should the government go in setting prices for prescription drugs?
A pilot project in which doctors provide primary care at home for very frail Medicare beneficiaries saved $25 million in 2014, and nine of the 14 practices participating earned bonuses totaling nearly $12 million.
Federal officials delayed the release of the ratings after the hospital industry and members of Congress objected to the formula, saying it worked against hospitals that take the patients that are the toughest to treat.
The U.S. faces a variety of serious concerns beyond just the future of the federal health law.
© 2026 KFF